Previous 10 | Next 10 |
Coronavirus Concerns Have Triggered Momentum In These Penny Stocks Last night U.S. President Trump discussed next steps for the coronavirus. This included a travel ban as well as another reminder to keep your hands clean (among other things). As a result, the market has dropped even lower on T...
3 Penny Stocks Turning Heads This Week When it comes to stocks trading under $5, or penny stocks , you really need to have a good handle on your personal risk tolerance. I’m not talking about how you play the lottery and handle yourself at a slot machine. I’m talking about inves...
3 Penny Stocks To Watch Right Now The stock market saw something it hasn’t in quite some time: a full halt. At the open today, the S&P opened roughly 7% lower than its previous closing price on Friday. This triggered a circuit breaker halt for 15 minutes. This is a safeguard against...
Speculation & News Are Driving Momentum For These Penny Stocks If there’s one thing we’ve learned from penny stocks it’s that speculation can make for exciting times. While these cheap stocks are already volatile and high risk, events like the novel coronavirus or COVI...
Novan (NASDAQ: NOVN ) falls sharply in early trading after pricing a public offering of 18.3M shares at $0.30 per share. More news on: Novan, Inc., Healthcare stocks news, Stocks on the move, Read more ...
MORRISVILLE, N.C., Feb. 27, 2020 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (NASDAQ:NOVN) today announced the pricing of the Company's previously announced underwritten public offering of 18,333,334 shares of common stock (or pre-funded warrants to purchase common stock in l...
MORRISVILLE, N.C., Feb. 27, 2020 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (NASDAQ: NOVN) today announced that it intends to offer and sell a combination of shares of its common stock (or pre-funded warrants to purchase common stock in lieu there...
Provides funds to evaluate the mechanistic antiviral activity of WH602 Novan to progress IND-enabling toxicology and pharmacology studies for WH602 Grant is additive to $223,000 Phase 1 NIH grant received in August 2019 Women’s health initiative focused on potential HPV ...
FDA grants Type C meeting for SB206 to be held on April 1, 2020 Last subject completes last visit, Week 24 safety evaluation Additional 12-week efficacy and safety data provided MORRISVILLE, N.C., Feb. 06, 2020 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or ...
Amarin (NASDAQ: AMRN ) resumed with Neutral rating and $22 (5% upside) price target at JPMorgan. Shares down 2% premarket. More news on: Amarin Corporation plc, Glaukos Corporation, Galapagos NV, Healthcare stocks news, Stocks on the move, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
– The Company and Ligand Pharmaceuticals sign agreement to sell substantially all of Novan’s assets under Section 363 of the U.S. Bankruptcy Code, along with a commitment from Ligand to fund $15 million in debtor-in-possession financing – – Progression toward...
DURHAM, N.C., June 05, 2023 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that it will host a live audio webcast of the Company’s 2023 Annual Meeting of Stockholders (“ASM”) being held on Tuesday, June 6...
– Company directing resources on the potential approval of berdazimer gel, 10.3% (SB206) for molluscum contagiosum – – Process to explore a sale or out-license of commercial assets or other business transaction continues – – Continued progress ...